Prognosis
Eli Lilly’s Virus Antibody Drug Starts Testing in Nursing Homes
- Antibody could work as alternative to vaccine for older people
- Co. to make 100,000 doses by year’s end if trial succeeds
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Eli Lilly & Co. will begin testing its Covid-19 antibody drug in nursing homes, a treatment with potential to protect vulnerable groups that vaccines may not cover.